A ctivation-induced deaminase (AID) catalyzes two B cell-specific DNA alteration events, somatic hypermutation (SHM) and class switch recombination (CSR) (1) . During SHM, point mutations are introduced into V region exons and the immediate downstream intronic J region, thereby enhancing the DNA sequence diversity of V regions to allow the selection of B cell clones with increased affinity for Ags (2) . To diversify Ab effector functions, a specific DNA recombination process termed Igh CSR occurs within the C region of the Igh gene (3, 4) . CSR targets highly repetitive and specific sequences termed switch (S) regions, which are located 59 of each set of C H exons except Cd (5) . AID introduces DNA double-stranded breaks (DSBs), the essential intermediate of CSR, to the upstream donor Sm and a downstream acceptor S region (3, 4) . The rejoining of the broken S regions is catalyzed via nonhomologous end-joining (6) (7) (8) (9) , which results in the switching of the C regions.
In response to Ags, activated B cells form specialized lymphoid structures termed germinal centers (GCs) in which both SHM and CSR ensue (10) . In GC B cells, robust SHM targets the assembled Igh and Igl V region exons and Igh S regions (11, 12) . CSR can be induced by T cell-dependent and independent Ags in vivo, and thus can occur in both GC and extrafollicular B cells (13) . Additionally, CSR can be induced in vitro by stimulating B cells with different activators, such as anti-CD40 or bacterial LPS in the presence of IL-4 (3, 4) , that enable the accessibility of a given S region for recombination (3, 14) . Because B cells activated with different stimuli undergo distinct differentiation pathways and display unique signatures of gene expression (15) , we hypothesize that the process to generate AID-mediated DSBs may be differentially regulated in distinct B cell populations.
AID-initiated DSBs occur in donor Sm and acceptor S regions that activate the ataxia telangiectasia mutated (ATM)-dependent DNA damage response (16, 17) . ATM rapidly phosphorylates numerous substrates, including histone H2AX, 53BP1, MDC1, and NBS1, that form large foci along flanking megabase chromatin regions (16, 17) . The DSB response is required for normal CSR, as deficiency in the DNA damage response factors causes a reduction in CSR (6, (16) (17) (18) (19) (20) . Furthermore, AID-dependent S region DSBs separate and progress into chromosomal breaks and translocations in the absence of a normal DSB response (6, (16) (17) (18) (19) (20) . Notably, all the analyses of DSB formation were performed in the cytokine-activated B cells in vitro. It has not been previously addressed whether in vivo Ag-stimulated GC B cells differ in their ability to acquire genomic instability.
AID functions via DNA deamination of cytosine, which is converted to uracil (21) , thereby resulting in a U:G mismatch. AID-initiated U:G mismatches are subsequently recognized by mismatch repair (MMR) and base excision repair pathways that eventually lead to SHM and CSR (22, 23) . Based on mutation analysis of MSH2 2/2 or MSH6 2/2 mice, MutS protein homolog (MSH) 2/MSH6 (mutS homolog 2/6) heterodimers are responsible for recognizing the U:G mismatches during MMR (23) (24) (25) (26) . Additionally, the uracil residues can be removed by uracil-DNA glycosylase (UNG) during base excision repair (2, 27, 28) . Therefore, the generation of mutations or DSBs requires both AID deamination and recognition of the AIDinitiated lesions by MMR and UNG. In the absence of MSH2 and UNG, AID-initiated deamination events are converted to either C→T or G→A mutations by replication machinery in the J H4 intronic region or S regions in GC B cells (27, 29) ; thus, this mutational signature represents the footprint of AID deaminase activity.
A central unresolved question in the AID field is how AIDmediated DNA alterations are specifically targeted to Ig loci, yet refrain from causing genome-wide damage given the potential of AID to access the genome widely to induce genomic instability at non-Ig loci (30) . Previous studies proposed that a differential DNA repair mechanism protects non-Ig loci from AID-mediated mutations (31) . However, it remains largely unknown how such a protective repair mechanism is regulated at non-Ig loci. c-myc is a frequent translocation partner of Ig loci in human mature B cell lymphomas (32) ; in fact, the Igh-c-myc translocation was the first molecularly characterized translocation (33, 34) . These translocations are thought to derive from GC B cells (35) . However, extensive sequencing studies of the c-myc locus in human memory B cells showed little SHM activity (36) (37) (38) , suggesting that c-myc is not an efficient AID target under physiological conditions. Later studies showed that the endogenous wild-type (wt) c-myc locus was protected from AIDmediated alterations in GC B cells (31) .
We recently demonstrated that the mutagenic activity of AID depends on its target sequence at a non-Ig locus, Bcl6 (39). Thus, we sought to test whether target DNA sequences could disrupt the protective mechanism by modifying the processing manner of AID-initiated lesions at the c-myc locus. To accomplish this goal, we established a knock-in (KI) model by inserting a bona fide AID substrate, an Sg2b sequence, into the first intron of the mouse c-myc gene via homologous recombination (c-myc Sg2b ). In the context of the Igh locus, the S region is critical for CSR and a substrate for AID-induced mutations. Thus, by inserting the Sg2b region into the c-myc locus, we can also investigate the influence of genomic context versus primary DNA sequences on AID targeting. Unexpectedly, our findings reveal that the inserted S region only enhances the c-myc genomic instability in the in vitro cytokine-activated B cells but not in GC B cells. Furthermore, we found that the presence or absence of an S region sequence does not alter the frequency of AID-mediated deamination in either GC or in vitro-activated B cells at the c-myc locus. Thus, our studies, to our knowledge for the first time, uncover a striking difference between GC and in vitro cytokine-activated B cells in generating genomic instability, and they demonstrate that AID-initiated lesions that occur at a similar frequency can be differentially processed in distinct populations of B cells. More importantly, our unique experimental systems provide insights into the differential influence of genomic context versus primary DNA sequences on AID-mediated mutagenesis.
Materials and Methods
Embryonic stem cell targeting and generation of c-myc Sg2b 
KI mice
An ∼4.6-kb BamHI fragment from the Sg2b genomic sequence (accession no. AJ851868) was targeted into the unique DraIII site between exons 1 and 2 of the c-myc locus. A 1.1-kb BamHI-BamHI 59 homology arm from a plasmid containing c-myc genomic DNA was cloned into a SalI site of the pLNtk targeting vector. A 3.3-kb BamHI-XhoI 39 homology arm containing c-myc genomic DNA was cloned into the XhoI site of the pLNtk targeting vector. An Ig2b-Sg2b fragment (40) was cloned into the DraIII site in the 39 homology arm. The targeting construct was transfected into TC1 embryonic stem (ES) cells. Correctly targeted clones were detected by Southern blot (EcoRI digest) with two probes that hybridized upstream of the 59 homology arm or downstream of the 39 homology arm. The 59 c-myc probe A was a 1.5-kb XbaI-XbaI fragment upstream of exon 1 and 39 probe B was a 1.5-kb XhoI-KpnI fragment downstream of exon 3. c-myc probe D was an XhoI-BamHI fragment in the first intron of c-myc. For deletion of the neo r cassette through two flanking loxP sites, targeted ES cell clones were infected with recombinant adenovirus that expressed Cre recombinase. The targeted c-myc Sg2b ES cells were injected into blastocysts to obtain germline transmission in 129 mice. Mice heterozygous for the c-myc Sg2b allele were interbred to generate mice homozygous for the targeted c-myc Sg2b allele. The KI allele was detected by PCR using the following primers: forward primer C (in c-myc intron), 59-GAA-GACTGCGGTGAGTCGTGATCT-39; reverse primer D (in the inserted S region), 59-GAAAGTGCCCTGGACCCCTGTTAACCACAC-39. Animal work was approved by the Institutional Animal Care and Use Committee of the University of Colorado Anschutz Medical Campus (Aurora, CO), National Jewish Health (Denver, CO), and the Children's Hospital in Boston (Boston, MA).
Cell sorting and flow cytometry
For SHM studies, spleen and mesenteric lymph nodes were dissected from immunized mice (see below) and single-cell suspensions were obtained. Cells were stained with peanut agglutinin (PNA)-FITC (Vector Laboratories) and B220-PE and sorted for B220 + and PNA high surface expression with FACSVantage (Becton Dickinson) or Beckman Coulter MoFlo XDP sorter (Miami, FL). Cells were collected and DNA was prepared for PCR amplification. Single-cell suspensions prepared from various lymphoid organs were characterized with the following mAbs: IgG1-FITC, B220-PE, B220-allophycocyanin, CD4-PE, CD8-CyChrome, CD3-FITC (BD Biosciences), and PNA-FITC (Vector Laboratories). All analyses were performed with a FACSCalibur (BD Biosciences), and results were analyzed with CellQuest or FlowJo software.
Mutation analysis and RT-PCR
The immunization protocol was described previously (39) . Briefly, SRBCs were injected i.p. into mice on days 0 and 5, and spleens and mesenteric lymph nodes were harvested 10 d after immunization. For c-myc locus mutation analysis, DNA was extracted from sorted GC B cells (B220 + PNA high ) or naive B cells (B220 + PNA low ) as described above or from the tail as a control for germline sequence. iProof high-fidelity DNA polymerase (Bio-Rad, Hercules, CA) was used to amplify the first intron region of the wt c-myc or c-myc Sg2b allele, PCR products were subsequently cloned into the p-GEM easy vector (Promega), and miniprep clones were sequenced. Sequences were analyzed with DNASTAR/SeqMan software and were aligned with the corresponding genomic sequences of c-myc (accession no. AC134611) or Sg2b (accession no. AJ851868, http:// www.ncbi.nlm.nih.gov/nuccore/126349412). Primers for wt c-myc allele were forward primer (primer A), 59-CGGGTCCGACTCGCCTCACT-39, reverse primer (primer B), 59-GACACCTCCCTTCTACACTCTAAACCG-39; primers for the c-myc Sg2b allele (C and D) are described above. A Fisher exact test (2 3 2 table, two-sided) for statistical significance was applied to compare mutation frequency between different regions or loci.
RT-PCR was performed as described previously (39) . GC B cells were isolated from wt or c-myc Sg2b/Sg2b homozygous mice. Total RNA was purified with TriPure (Roche) and used for the reverse transcription reaction (Promega). The forward primer for c-myc (in exon 1) was 59-CGGGTCCGACTCGCCTCACT-39; the reverse primer for c-myc (in exon 2) was 59-GCTCTGCTGTTGCTGGTGATAGAA-39. Actin primers were described previously (39) .
B cell culture, fluorescence in situ hybridization, and translocation PCR Splenic B cells were isolated from naive mice without immunization, purified by enriching the resting CD43
2 B cell population (StemCell Technologies, Vancouver, BC, Canada), activated with anti-CD40 and IL-4 as described previously (41) , and collected 4 d after culture for fluorescence in situ hybridization (FISH) analysis or mutation analysis. GC (B220 + PNA high ) and naive B cells (B220 + PNA low ) from immunized mice were sorted as described above (see section on cell sorting and flow cytometry), cultured for a short period of time (8-12 h) in the presence of anti-CD40 (1mg/ml, BD Pharmingen) and IL-4 (20 ng/ml, Fisher Scientific), and employed for FISH analysis. This short duration of culture was required to generate enough metaphases for FISH analysis. FISH analysis for Igh and c-myc loci and Igh-c-myc translocation PCR were performed with specific probes and primers as previously described (41) . The Igh-cmyc translocation PCR has been well established and employed by several independent groups (41) (42) (43) . Briefly, nested PCRs were performed using an aliquot of genomic DNA (usually ranging from 200 to 400 ng per reaction) isolated from cytokine-activated B cells of various genotypes. Typically, 24 reactions were performed for each experiment, which represents ∼1-2 million cells tested. The products of first PCR were employed as the templates for the second PCR, and the products of the second PCR were resolved on the gel for probe hybridizations. 
Retroviral infection and culture of primary T cells
Retroviral infection was performed as described previously (41) . Briefly, Phoenix cells were cultured with DMEM and primary T or B cells were culture with RPMI 1640. All culture media were supplemented with 10% FBS, antibiotics (penicillin/streptomycin, Invitrogen), 10 mM HEPES, nonessential amino acids (Cellgro), sodium pyruvate, and L-glutamine. Empty vector expressing GFP or the vector expressing N-Flag-AID-IRES-GFP (50 mg) were transfected into Phoenix packaging cells via calcium phosphate precipitation. An N terminal Flag tag was added to Aicda cDNA via a PCR approach and the resulting PCR fragments were cloned into the pMX-IRES-GFP vector. Retroviral supernatants were collected at 48 and 72 h after transfection and used for infecting primary T cells. Primary T cells were purified from c-myc Sg2b /ATM 2/2 mice by enriching CD43 + cells (StemCell Technologies), cultured for 2 d with Con A (1.5 mg/ml), and infected with retroviral supernatant as described previously (41) . Two days postinfection, cells were collected and GFP + cells were sorted for subsequent FISH analysis and Western blot. Anti-AID Ab (39) was used at a dilution of 1:1000 and anti-Flag Ab (Sigma-Aldrich) was used to distinguish the exogenously expressed AID in T cells.
Results

Generation of c-myc
Sg2b KI mice
It has been proposed that certain non-Ig loci such as c-myc are protected from AID-mediated mutations (31) . To investigate the protective mechanism and better define its role in regulating B cell genomic instability during immune responses, we established the c-myc Sg2b KI model. Sg2b, the S region located upstream of Cg2b exons, was chosen because previous studies have shown that Sg2b undergoes internal deletions in random genomic locations in B cell lines (40) , suggesting it could be targeted by AID in a position-independent manner. Additionally, our model allows us to test whether an S region can induce specific AID targeting to a locus such as c-myc that normally has little SHM activity (36) (37) (38) . Using homologous recombination in ES cells, we inserted the genomic fragment of Sg2b into c-myc intron 1 ( Fig. 1) , where it was transcribed by the endogenous c-myc promoter. Mice heterozygous for the Sg2b insertion (c-myc Sg2b/+ ) were bred to yield homozygous KI mice (c-myc Sg2b/Sg2b ). The latter were viable and fertile and had normal lymphocyte development and CSR in vitro (data not shown). These data indicate that the insertion of the S region did not perturb c-myc functions because c-myc deficiency leads to embryonic lethality (44). Furthermore, the transcript level of the c-myc gene in the homozygous KI B cells appeared to be normal, suggesting that the inserted S region did not significantly affect the overall transcription of the c-myc locus (see below).
The inserted S region mutated at an extremely low frequency and did not enhance the genomic instability of the c-myc locus in Ag-stimulated GC B cells
To test whether the c-myc
Sg2b allele is an AID target in GC B cells, c-myc Sg2b/+ or c-myc Sg2b/Sg2b mice were immunized with SRBC Ag. Genomic DNA was purified from the sorted B220 + PNA high GC or B220 + PNA low naive B cells from the immunized mice. We employed a PCR approach with specific primers designed for the wt versus c-myc Sg2b allele (Supplemental Fig. 1A ), and the amplified PCR products were subcloned and sequenced for mutational analysis. The sequenced regions for both alleles were delineated in detail with the AGCT motifs marked (Supplemental Fig. 1B, 1C ). The mutation frequency of the wt c-myc allele in the GC population was extremely low and comparable to the background level of mutations detected in the B220 + PNA low population or tail DNA (Table I) . Unexpectedly, we found that the inserted Sg2b region also mutated at an extremely low frequency comparable to that observed in the wt c-myc first intron region (Table I) . Moreover, the mutation frequency of the inserted Sg2b region was similar in the B220 + PNA high , B220 + PNA low population or tail DNA (Table I ). The J H4 intronic region was also sequenced as a positive control, which had a much higher level of mutations than the wt or c-myc Sg2b allele in GC B cells (Table I) . Thus, our results demonstrate that the wt c-myc sequence has an extremely low level of mutations in the in vivo Ag-stimulated GC B cells. Surprisingly, the insertion of an S region sequence, a bona fide AID target, did not enhance the mutation frequency of the c-myc locus.
Next, we investigated whether the inserted S region influenced the level of genomic instability at the c-myc locus in GC B cells by measuring the frequency of DSBs or translocations. To precisely quantify these abnormalities occurring within the c-myc locus, we employed a two-color FISH assay using two BACs that flank the 59 or 39 ends of the c-myc locus, respectively. The Table I ). Additionally, naive B cells also harbored an extremely low level of c-myc genomic instability ( Fig. 2A , Supplemental Table I ). Thus, we conclude that the inserted Sg2b region does not lead to a higher level of c-myc locus DSBs or translocations.
However, it remains possible that the inserted S region might increase the frequency of DSBs that are properly repaired in the presence of a normal DSB response. To test this possibility, we crossed the c-myc Sg2b allele into ATM 2/2 mice that have an impaired DSB response and assayed for genomic instability of the c-myc locus in the double mutant c-myc
However, we still did not detect a significant level of c-myc locus abnormalities in these c-myc Sg2b /ATM 2/2 GC B cells ( Fig. 2A) .
Consistently, we found that the mutation frequency of the inserted Sg2b region in the c-myc Sg2b /ATM 2/2 GC B cells was still extremely low (Table I) (Fig. 2D) . Additionally, we found that the GC reactions were quite comparable between wt and c-myc Sg2b/Sg2b homozygous mice (Fig. 2D) . Given that c-myc is required for initiating and maintaining the GC reaction (46), our results show that the insertion of the Sg2b region into the c-myc locus has no obvious effects on the functionality of c-myc and does not affect GC reactions.
The inserted S region led to an increased level of c-myc locus abnormalities in cytokine-activated B cells
Given that B cells activated with different stimuli undergo distinct differentiation pathways with unique signatures of gene expression (15), we hypothesized that the process to generate AID-mediated DSBs might be differentially regulated in distinct B cell populations. To test this hypothesis, we performed FISH analysis to investigate whether the inserted S region affects the frequency of c-myc locus genomic instability in another population of B cells, had comparably low levels of c-myc locus abnormalities (Fig. 3A , Supplemental Table II ). In contrast, cytokine-activated B cells from c-myc Sg2b /ATM 2/2 mice harbored a significantly higher level of c-myc locus abnormalities (Fig. 3A , Supplemental Table II) . Representative examples are shown for such c-myc DSBs/translocations (Fig. 3B) . Among the c-myc locus abnormalities observed, .80% were breaks or breaks/translocations, suggesting that they were being induced in a short period of time in the culture (Fig. 3C) . Thus, we conclude that the inserted Sg2b region enhances the genomic instability of the c-myc locus, To further demonstrate that the inserted Sg2b region increases c-myc locus genomic instability, we successfully employed the PCR approach (Fig. 4A) (Fig. 4C) , demonstrating that insertion of the S region in the c-myc locus enhanced the level of Igh-c-myc translocation. Translocation breakpoints occurred at the inserted S region or endogenous c-myc intronic sequences (data not shown). Therefore, our data convincingly demonstrate that insertion of the S region enhances the level of genomic instability at the c-myc locus in cytokine-activated B cells.
AID expression is both sufficient and necessary for elevated c-myc genomic instability
We predicted that the S region-mediated c-myc locus abnormalities in activated c-myc Sg2b /ATM 2/2 B cells were AID-dependent.
To test our hypothesis, we employed two approaches. First, we tested whether AID expression was sufficient to induce c-myc locus abnormalities by ectopically expressing AID in primary T cells. Splenic T cells were isolated from naive c-myc
Sg2b
/ATM 2/2 mice, activated, and infected with retroviruses expressing N-terminal Flag-tagged AID and EGFP simultaneously via IRES, or empty vector as a negative control. GFP + T cells were sorted and employed for Western blotting to confirm the exogenous expression of Flag-tagged AID, using anti-CD40/IL-4-activated B cells as positive controls (Fig. 5A) . FISH analysis showed that ectopically expressed AID led to a higher level of c-myc locus genomic instability in the activated c-myc Table III) . Additionally, we assayed noninfected T cells or activated B cells from the same mice for c-myc locus abnormalities and found that the former had an extremely low level of c-myc locus abnormalities whereas the latter displayed a similar level of c-myc locus abnormalities to the other B cell samples analyzed (Fig. 3A , Supplemental Table III) . Thus, our data demonstrate that AID is capable of inducing DSBs/translocations in non-B cells. Second, we tested whether AID was required for the S regionmediated c-myc locus abnormalities. We crossed AID deficiency (1) into c-myc Sg2b /ATM 2/2 mice and assayed for the level of c-myc locus genomic instability in the triple mutant B cells activated with anti-CD40 and IL-4. Our data clearly showed that the increased c-myc locus abnormalities in c-myc
were dependent on AID expression, because AID deficiency abrogated the formation of these DSBs/translocations (Fig. 3A , Supplemental Table II) . Thus, we conclude that the increased c-myc genomic instability is both AID-and S region-dependent.
The inserted S region was targeted by AID deamination in distinct populations of B cells at a comparable frequency
The generation of DSBs requires AID deamination and recognition of AID-initiated lesions via MMR or UNG. Because our data clearly show that the inserted S region enhances the level of c-myc DSBs/translocations in the cytokine-activated B cells but not in GC B cells (Figs. 2, 3 converted to either C→T or G→A mutations by replication machinery (27, 29) ; thus, these mutations represent the footprint of AID deamination. The compound mutant c-myc Sg2b/+ /DKO mice were immunized with SRBC Ag and GC B cells were isolated for mutational analysis. Additionally, splenic B cells were isolated from naive c-myc Sg2b/+ /DKO mice, activated by anti-CD40/IL-4 for 4 d and harvested for mutational analysis. We analyzed the c-myc Sg2b KI allele in the MSH2 2/2 UNG 2/2 GC versus cytokineactivated B cells and found that the mutation frequency of the KI allele was quite comparable between the two populations (Fig. 6A , column 7 versus 9, Tables II, III) . Thus, these data show that the c-myc Sg2b KI allele is targeted by AID in GC and cytokineactivated B cells at a similar frequency. We conclude that a differential AID targeting probably does not contribute significantly to the S region-mediated genomic instability at the c-myc locus.
Consistent with previous studies (31), we found that the mutation frequency of the wt c-myc first intron region was much higher in MSH2 2/2 UNG 2/2 or UNG 2/2 GC B cells compared with wt controls (Fig. 6A , column 1 versus 5 and 6; Tables I, II) . In contrast, both wt and c-myc Sg2b KI alleles harbor a very low level of mutations in the GC B cells of c-myc
2/2 mice (Fig. 6A , columns 3 and 4; Table II) . Similar to what we observed for the wt c-myc intron region, the mutation frequency of the inserted Sg2b region was also much higher in c-myc Sg2b/+ /DKO GC B cells (∼10-fold) than in c-myc Sg2b GC B cells (Fig. 6A , column 2 versus 7; Table I, II) . Furthermore, we found that both wt and c-myc Sg2b KI alleles mutated at a similar frequency in the GC B cells of c-myc Sg2b/+ /DKO mice (Fig. 6A, column 6 versus 7 ; Table II ). Taken together, our data show that the AID-induced DNA lesions are normally repaired in an error-free manner at the c-myc 
Differential level of c-myc transcripts between GC and cytokine-activated B cells
Previous studies clearly showed that transcription is required for SHM (38, 48, 49) . However, it remains unclear whether the level of transcription correlates with AID targeting efficiency. Because we detected no difference in AID deamination among different populations, we next examined the transcript levels of c-myc in GC or cytokine-activated B cells from wt or c-myc Sg2b/Sg2b homozygous mice that harbor the inserted S regions at the c-myc locus for both alleles. Our semiquantitative RT-PCR analysis showed that GC B cells expressed a much lower level of c-myc transcripts than do cytokine-activated B cells, regardless of genotypes (Fig. 6B) . Consistently, the level of c-myc transcripts was ∼2.7-fold less in wt GC B cells than in cytokine-activated B cells as shown by microarray analysis (Fig. 6C) . Thus, we conclude that the level of c-myc transcription is lower in GC than cytokineactivated B cells. However, the c-myc transcript level is relatively comparable between wt and c-myc Sg2b/Sg2b B cells in both GC and cytokine-activated B cells (Fig. 6B) . These data suggest that the inserted S region does not significantly affect the overall transcription of the c-myc locus. Taken together, our data indicate that, within a certain range, the difference in transcription levels has no obvious effects on AID targeting efficiency (deamination) whereas it might influence the processing and repairing of such AID-initiated lesions.
Discussion
We employ a genetic approach to address the fundamental aspects of the current models for AID-mediated sequence diversification during B cell activation. We present three unexpected novel findings: 1) there exists a clear difference between GC and in vitro cytokine-activated B cells in the context of AID-associated genomic instability; 2) locus-specific regulatory mechanisms may override the effects of S region sequence motifs in determining AID-mediated mutation frequency; and 3) AID-initiated lesions that occur at a similar frequency can be differentially processed in distinct B cell populations.
Using our c-myc Sg2b KI mouse model, we detected a high level of c-myc locus DSBs/translocations in the absence of ATM in the cytokine-activated B cells, which are both AID-and S regiondependent. In striking contrast, we observed no significant level of c-myc genomic instability in the GC B cells. Thus, our findings clearly reveal a difference between the populations of GC and in vitro cytokine-activated B cells in their ability to acquire genomic instability, thereby suggesting that conclusions drawn from studies using one population may not be generalizable to others. Additionally, our data suggest that in vitro activation of B (or T) cells might have different effects from what occurs in vivo in a GC response. Because previous studies in the field often rely on in vitro activation of naive B cells as the model system (41, 50-52), we may need to take into consideration the difference between the two experimental models and techniques when investigating CSR and translocation mechanisms.
Based on the previous studies showing the superior ability of S region sequences in attracting AID (5, 29, 39, 40, 53-59), we predicted that the KI Sg2b sequence might enhance AID targeting to the c-myc locus and lead to a higher level of mutations or genomic instability via disrupting the protective repair mechanism proposed to operate at non-Ig loci such as c-myc (31, 60) . Unexpectedly, we found that the presence or absence of an S region at the c-myc locus did not alter the frequency of AID-mediated deamination in either GC or in vitro cytokine-activated B cells, seemingly in contrast to the commonly accepted view that S region sequences affect AID targeting (30) . The unexpected results are not in line either with our recent study that demonstrated a critical role of target DNA sequences in enhancing AID's mutagenic activity at a non-Ig locus, Bcl6 (39) . In the previous model, we found that the inserted Sg1 region mutated at a 10-fold higher frequency than did the intronic sequence of Bcl6 (39). Whereas S region sequences are indeed optimal targets of AID in the context of the Igh locus (18, 30) , we propose that the capacity of such sequences to increase the frequency of mutations or DSBs at a given locus is dependent on the "genomic context" of the particular locus. However, genomic context represents a broad concept; to define its specific influence on AID-mediated mutagenesis, we propose that locus-specific cis regulatory elements probably account for the disparity between c-myc and Bcl6 loci in terms of AID targeting. Furthermore, we propose that locus-specific regulatory elements play a more dominant role in determining the frequency of AID-mediated mutations, potentially by permitting or prohibiting the S region-mediated sequence-specific effects. 
DIFFERENTIAL PROCESSING OF AID-INITIATED LESIONS
Recent studies have highlighted a critical role of cis regulatory elements in AID targeting to Ig loci (61) (62) (63) (64) (65) (66) . Notably, SHM in the rearranged V H regions is almost completely abrogated in the GC B cells of mice lacking the entire 30 kb of the Igh 39 regulatory region (67) . Therefore, it is conceivable that the locus-specific cis regulatory elements may account for the different mutation frequency between the Bcl6 and c-myc loci. For instance, the transcription levels of c-myc and Bcl6 might be different in GC B cells (68) . Bcl6 is highly transcribed in GC B cells expressing a much higher level of transcript than that of naive B cells (68) . In contrast, the transcript level of c-myc in GC B cells is either comparable to or even lower than that of naive B cells (46, 68) . Thus, the transcriptional microenvironment of these two loci seems to differ greatly, which may set the predetermined mutational threshold in these two loci. In support of this notion, the Bcl6 locus is a physiological target of AID in wt GC B cells (31, 39, 69) whereas the c-myc locus shows an extremely low level of mutations. Taken together, our unique experimental systems reveal the impact of genomic context versus primary DNA sequences on AID-mediated mutagenesis (Fig. 7) . With regard to different S regions, Sg2b was chosen because previous studies have shown that Sg2b undergoes internal deletions in random genomic locations in B cell lines (40) , suggesting it could be targeted by AID in a position-independent manner. Both mouse Sg1 and Sg2b regions carry 49-bp repeats, although the density of such repeats appears to be higher in the Sg1 region (5) . However, the density of AGCT motifs, another evolutionarily conserved motif for AID targeting (5, 70) , is comparable between the two inserted S regions (0.043 in Sg2b versus 0.038 in Sg1). It remains unknown whether these S regions are inherently different in their ability to attract AID. To test this question, a systematic approach needs to be employed by knocking in these sequences into a locus well targeted by AID, for example, the endogenous V region locus. In such a scenario, all the test sequences would be under the control of the same regulatory elements. Hence, we cannot completely exclude the possibility that the inherent features of Sg1 and Sg2b regions may contribute to the differential phenotypes in the two KI models, albeit it is much less likely to have a major effect.
We found that the GC B cells and in vitro cytokine-activated B cells behave quite differently in terms of DSB generation. However, we show that there is no difference in AID deamination (Fig. 6A) ; therefore, we reason that the processing of AIDinitiated lesions must be differentially regulated in these two populations, potentially by factors such as target DNA sequences, transcriptional regulation, chromatin architecture, or accessibility of DNA repair factors. AID-initiated U:G mismatches can be recognized by UNG or MSH2/MSH6, leading to qualitatively distinct outcomes. Whereas UNG appears to play a more dominant role in inducing DSBs during CSR, MSH2 is required for inducing A/T mutations during SHM of the V region (2, 23, 25, 27, 28) . We propose that differential transcription levels might affect how DNA repair factors access the DNA templates via regulating the formation of a higher order DNA structure in the inserted S region in distinct populations. In this regard, we suggest that S regions may harbor unique features such as repetitive sequence motifs (5) that render them more prone to form DSBs. In line with this notion, we found that the level of c-myc transcripts was significantly higher in the cytokine-activated B cells than in GC B cells. We propose that such a relatively higher level of transcription might support a permissive local microenvironment facilitating S regions to form higher order structures for DSB generation, thereby leading to an enhanced level of c-myc locus genomic instability in the in vitro cytokine-activated B cells.
In contrast to the c-myc locus, which exhibits a differential repair in distinct populations, the Igh locus appears to behave differently (Fig. 7) , in conjunction with previous analysis (9, 19, 20, 27, 29, 41, 71) , and our data show that AID-initiated lesions in the S regions of the Igh locus consistently undergo error-prone repair that leads to a high level of DSBs in both GC and in vitro cytokine-activated B cells. Notably, recent studies showed that AID-induced DSBs accumulate in Sm regions in the absence of ATM (72) . However, ATM deficiency caused the reduction of mutations and DSB formation at the downstream Sg regions (72) . These data suggest that ATM normally enhances the activity of AID at the downstream acceptor Sg regions, whereas, in the ab- sence of ATM, Sm DSBs probably accumulate owing to a lack of recombination partners (72) . Consistently, our data showed that ATM is required for a normal level of GC responses. Similar to the Igh locus, certain non-Ig loci such as Bcl6 and Cd83 undergo error-prone repair in GC B cells because the mutation frequency of such loci is comparable between wt and MSH2 2/2 UNG 2/2 mice (31). Thus, we propose that locus-specific regulatory mechanisms (e.g., transcription) appear to not only dominate the effects of S region sequences on AID targeting frequency, but they also influence the repair manner of AID-initiated lesions. The GC response in vivo typically involves both SHM and CSR, whereas in vitro stimulation with cytokines or other activators almost exclusively induces CSR. In this context, all studies using in vitro-stimulated naive B cells show clear evidence of CSR, as well as the introduction of "CSR-associated" point mutations upstream of the Sm repeats (27, 29, 71, 73) , but no evidence of mutations occurring in the V region. Clearly, VDJ exon and Sm regions are both transcribed in the in vitro-activated B cells (53) , and AID is also active. One important implication of this puzzling phenomenon is that the AID-induced mutations in the V region (SHM in the traditional sense) are distinct from AID-induced mutations upstream of the S region repeats. Furthermore, we envision that these two processes are not induced by the very same mechanism, albeit they may share common factors such as AID (1, 74) ; instead, there must be distinct factors that are specifically required to induce V region mutations compared with mutations upstream of Sm. Such distinct factors are probably associated with the GC microenvironment and induced by the Ag-specific T cells. Thus, we propose that V region mutations are induced differently from mutations occurring in other loci. In this context, we think the c-myc gene undergoes the "CSR-associated AID-mediated mutagenesis," that is, a mistargeted "CSR including S region SHM."
When isolating GC B cells it is extremely difficult to determine what happens at the time of isolation compared with what happened since the initiation of the GC response. Hence, it is possible that SHM (i.e., V region mutation) and CSR occur sequentially rather than simultaneously; addressing this question will require a better experimental system to track the mutations in V regions versus DSBs in S regions in real time. It is possible that the GC cells isolated in our study mostly undergo "V region SHM," whereas the in vitro-activated B cells exclusively undergo CSR and "S region SHM." Although it is impossible to determine the status of individual GC B cells, our data show that, as a pooled population, some fraction of these B cells at least undergo DSB generation at the Igh locus (Fig. 2) . Although we cannot pinpoint the exact location of these DSBs within the Igh locus, it is conceivable to suggest that most of them occur during Igh CSR. Thus, it remains equally possible that a small fraction of GC B cells isolated are capable of undergoing CSR and "S regionlike SHM." Indeed, we think that the c-myc gene undergoes such a mutagenic process in GC B cells; however, almost all of these mutations are corrected properly due to error-free repair in this population (Fig. 7) . 
